REGULATED PRESS RELEASE published on 10/23/2023 at 07:00, 2 years 10 months ago Biophytis announces the launch of a rights issue with maintenance of shareholders’ preferential subscription rights to continue the execution of its strategic roadmap
PRESS RELEASE published on 09/27/2023 at 23:15, 2 years 11 months ago Biophytis releases its half-yearly accounts as of 30 June 2023 and provides an update on its operations
PRESS RELEASE published on 09/25/2023 at 07:06, 2 years 11 months ago Biophytis and Skyepharma sign a Partnership Agreement for the Production of Sarconeos (BIO101)
PRESS RELEASE published on 09/19/2023 at 07:00, 3 years ago Biophytis provides an update on its early access programs for Sarconeos (BIO101) in the treatment of severe forms of COVID-19
PRESS RELEASE published on 09/14/2023 at 07:00, 3 years ago Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer
PRESS RELEASE published on 09/11/2023 at 07:00, 3 years ago Biophytis obtains FDA Authorization to initiate the SARA-31 phase 3 study in sarcopenia
PRESS RELEASE published on 09/04/2023 at 23:00, 3 years ago Biophytis to Participate at the H.C. Wainwright 25th Global Investment Conference in New York
PRESS RELEASE published on 08/16/2023 at 07:00, 3 years 1 month ago Biophytis announces next regulatory steps in Europe and the United States for its COVA project
PRESS RELEASE published on 08/08/2023 at 07:00, 3 years 1 month ago Biophytis receives a positive opinion for its SARA-31 phase 3 study in sarcopenia in Europe
PRESS RELEASE published on 07/20/2023 at 07:00, 3 years 2 months ago Biophytis: Biophytis has requested a pre-submission meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the treatment of COVID-19
Published on 09/19/2026 at 00:55, 2 days 6 hours ago Gossan Resources Announces Changes to Board and Management
Published on 09/18/2026 at 22:00, 2 days 9 hours ago Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 2 days 11 hours ago Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/18/2026 at 14:30, 2 days 17 hours ago AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Published on 09/21/2026 at 07:29, 16 minutes ago EQS-Adhoc: Berentzen-Gruppe AG signs business combination agreement with Sazerac and supports voluntary public takeover offer to all shareholders at a price of EUR 5.55 per share
Published on 09/21/2026 at 07:15, 31 minutes ago EQS-WpÜG: Takeover Offer / Target company: Berentzen-Gruppe Aktiengesellschaft; Bidder: Blitz 26-877 GmbH (zukünftig Sazerac Germany Holding GmbH)
Published on 09/21/2026 at 07:05, 41 minutes ago New De'Longhi Study Reveals Europe's "Signature Order" Coffee Culture Across 35 Cities
Published on 09/21/2026 at 07:00, 46 minutes ago Strongest half-year in Curatis’s history — revenue up 51% and significant progress on corticorelin (C-PTBE-01)
Published on 09/21/2026 at 07:00, 46 minutes ago Arbonia is selling its former corporate centre for approx. CHF 21 million
Published on 09/21/2026 at 07:00, 46 minutes ago Peugeot Invest takes a stake in Mérieux NutriSciences
Published on 09/18/2026 at 18:34, 2 days 13 hours ago Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/17/2026 at 17:40, 3 days 14 hours ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
